2018
DOI: 10.3389/fphar.2018.00935
|View full text |Cite
|
Sign up to set email alerts
|

Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…Mechanistically, this might be explained by a direct interaction of the MEK inhibitor with AHR activity. In fact, several structurally related protein kinase inhibitors, including other MEK inhibitors, such as PD98059 and U0126, have been previously identified to serve as AHR ligands and modulate downstream responses [180]. Moreover, a direct interaction of AHR with the BRAF inhibitor vemurafenib has been described in melanoma cells [181] as well as in T cells and keratinocytes [182].…”
Section: Ahr and Skin Cancermentioning
confidence: 99%
“…Mechanistically, this might be explained by a direct interaction of the MEK inhibitor with AHR activity. In fact, several structurally related protein kinase inhibitors, including other MEK inhibitors, such as PD98059 and U0126, have been previously identified to serve as AHR ligands and modulate downstream responses [180]. Moreover, a direct interaction of AHR with the BRAF inhibitor vemurafenib has been described in melanoma cells [181] as well as in T cells and keratinocytes [182].…”
Section: Ahr and Skin Cancermentioning
confidence: 99%
“…Low molecular kinase inhibitors are widely used to examine the function of kinases, but some inhibitors exhibit unexpected side effects. For instance, the p38 inhibitor SB203580 is a potent agonist of aryl hydrocarbon receptor (AhR) [140,141], which is a ligand-activated transcription factor and key regulator of xenobiotic metabolism, and AhR activation induces Cyp1a1 gene expression via xenobiotic responsive element (XRE) in Hepa 1c1c7 and HepG2 cells [142]. A complex effect of SB203580 is observed in HepG2 cells, which express high AhR levels [143].…”
Section: Discussionmentioning
confidence: 99%
“…A special case of off-target effects by protein kinase inhibitors is the modulation of the activity of xenosensing receptors of the chemical defense system, such as aryl hydrocarbon receptor or pregnane X receptor (PXR, NR1I2), a ligand-activated transcription factor of the nuclear receptor family. Activation of PXR induces drug detoxification and/or elimination, which may alter pharmacokinetics of the respective kinase inhibitors and potentially result in loss of efficacy [5]. However, PXR is not only a master regulator of drug detoxification [6], but also it was shown to modulate context-dependent tumor growth [7] and to promote cancer drug resistance [8,9], if activated in cancer cells.…”
Section: Introductionmentioning
confidence: 99%